NCT03451110View on ClinicalTrials.gov

Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

March 23, 2018

Study Completion Date

March 23, 2018

Conditions

Healthy Subjects

Interventions

DRUG

lemborexant

oral tablet

DRUG

Loestrin

oral tablet

DRUG

famotidine

oral tablet

DRUG

fluconazole

oral tablet

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

All Listed Sponsors

collaborator

Purdue Pharma LP

INDUSTRY

lead

Eisai Inc.

INDUSTRY

NCT03451110 - Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects | Biotech Hunter | Biotech Hunter